Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article - Biomedical Research (2017) Volume 28, Issue 14

An evaluation of 182 cases with Henoch-Schonlein purpura (HSP) in China: A retrospective study and follow-up

Objective: To clinically evaluate the characteristics, treatment methods and outcome of Henoch- Schonlein purpura (HSP).

Methods: The clinical data, of 182 HSP children treated at Shaanxi Provincial People's Hospital in Xi’an, from January 2010 to October 2012, was collected and analyzed accordingly.

Results: (1) Majority of HSP sufferers were 7-14 years old (51.65%), followed by 4-6 years old (41.76%), and under 3 years of age (6.59%). Amongst them the school going children consisted of 132 patients (72.53%). (2) The first sign of HSP was palpable skin purpura, observed in a total of 117cases (48.34%) (3) Glucocorticoid therapy is significantly effective as 74 out of 79 (93.67%) cases of children treated by glucocorticoid therapy improved significantly.

Conclusions: HSP can present at any age, but is most common in school going children. More effective and aggressive treatment must be used to avoid the end-stage renal disease. Glucocorticoid treatment is effective for patients with severe abdominal pain and gastrointestinal bleeding, and the early short-term use of Prednisone results in quick recovery. Combined therapy with immune inhibitor is an appropriate therapeutic regimen for patients with nephrotic proteinuria.

Author(s): Fuyong Jiao, Bilal Haider Shamsi, Zhilong Mu, Na Gao, Yuan Fang, Ali Raza

Abstract Full Text PDF